MENU
TBPH
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Theravance Biopharma (TBPH) Ownership - Who owns Theravance Biopharma?
Industry: @Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
Ugland House, South Church Street
Phone
+1 650 808-6000
Employees
99
Web
https://www.theravance.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
478.47M
P/E Ratio
N/A
Total Cash
91.36M
Projected Growth
N/A
Total Debt
44.98M
Revenue
63.19M
Risk (Beta)
0.02
Dividend Yield
N/A
Total Cash/Share
1.86
Total Debt/Equity
N/A
Revenue/Share
1.29 USD as % of share price
Fundamentals
TBPH
Capitalization
478M
P/E Ratio
N/A
Risk (Beta)
0.02
Dividend Yield
N/A
Total Cash
91.4M
Total Cash/Share
1.86
Total Debt
45M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.29%
Revenue
63.2M
ROE
N/A
Book Value
186M
P/B Ratio
2.58
Cash Flow
N/A
Earnings
-1.03
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
4.97
Current Revenue Per Employee
170383.84
Dividends Per Share - Security
N/A
EBITDA
-33.83M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-12.84
Shares Held By Institutions
1.93B
Shares Outstanding - Current
49.2M
Total Liabilities
170M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-11.388
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of small molecule pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
Ugland House, South Church Street
Phone
+1 650 808-6000
Employees
99
Web
https://www.theravance.com